0

    530057

    VIVANZA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Vivanza Biosciences Limited Share Price Today

    Investment Returns

    Over 1 Month 4.67% Over 3 Months -14.35% Over 6 Months -17.12% Over 1 Year -14.76%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Vivanza Biosciences Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 7.20
    • P/E Ratio (TTM) 19.89
    • Beta 0.47
    • Book Value / share 1.10
    • Return on equity -16.02%
    • EPS (TTM) 0.09
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.27
    info icon alternate text

    Vivanza Biosciences Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 5.75
    Operating Expense 5.88
    Net Profit -0.27
    Net Profit Margin (%) -4.69
    Earnings Per Share (EPS) -0.07
    EBITDA -0.03
    Effective Tax Rate (%) -116.66
    Particulars DEC 2025 (Values in Cr)
    Revenue 44.93
    Operating Expense 44.85
    Net Profit 0.16
    Net Profit Margin (%) 0.35
    Earnings Per Share (EPS) 0.04
    EBITDA 0.25
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 53.73
    Operating Expense 53.27
    Net Profit 0.46
    Net Profit Margin (%) 0.85
    Earnings Per Share (EPS) 0.12
    EBITDA 0.51
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 7.82
    Operating Expense 7.82
    Net Profit 0.02
    Net Profit Margin (%) 0.25
    Earnings Per Share (EPS) 0.00
    EBITDA 0.10
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.17
    Operating Expense 1.15
    Net Profit -0.97
    Net Profit Margin (%) -570.58
    Earnings Per Share (EPS) -0.24
    EBITDA -0.88
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 112.23
    Operating Expense 111.82
    Net Profit 0.38
    Net Profit Margin (%) 0.33
    Earnings Per Share (EPS) 0.09
    EBITDA 0.82
    Effective Tax Rate (%) 26.92
    Particulars MAR 2025 (Values in Cr)
    Revenue 2.94
    Operating Expense 3.67
    Net Profit -0.70
    Net Profit Margin (%) -23.80
    Earnings Per Share (EPS) -0.17
    EBITDA -0.32
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 14.41
    Operating Expense 14.04
    Net Profit 0.32
    Net Profit Margin (%) 2.22
    Earnings Per Share (EPS) 0.08
    EBITDA 0.85
    Effective Tax Rate (%) 25.58
    Particulars MAR 2023 (Values in Cr)
    Revenue 14.21
    Operating Expense 13.91
    Net Profit 0.57
    Net Profit Margin (%) 4.01
    Earnings Per Share (EPS) 1.42
    EBITDA 1.10
    Effective Tax Rate (%) 17.39
    Particulars MAR 2022 (Values in Cr)
    Revenue 9.15
    Operating Expense 9.52
    Net Profit 0.46
    Net Profit Margin (%) 5.02
    Earnings Per Share (EPS) 1.16
    EBITDA 0.88
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 0.99
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.61
    EBITDA Margin -4.04
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.16
    ROE % 12.60
    ROCE % 10.23
    Total Debt to Total Equity 1.51
    EBITDA Margin 4.06
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.02
    ROE % 14.84
    ROCE % 10.65
    Total Debt to Total Equity 1.78
    EBITDA Margin 6.46
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 8.73
    ROE % 8.25
    ROCE % 10.96
    Total Debt to Total Equity 0.88
    EBITDA Margin 7.40
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 7.90
    ROE % 2.26
    ROCE % 15.32
    Total Debt to Total Equity 0.12
    EBITDA Margin 6.07
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 1.01
    ROE % -16.02
    ROCE % -3.87
    Total Debt to Total Equity 1.07
    EBITDA Margin -11.22
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.18
    ROE % 7.02
    ROCE % 8.98
    Total Debt to Total Equity 1.08
    EBITDA Margin 5.97
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.10
    ROE % 13.57
    ROCE % 11.56
    Total Debt to Total Equity 1.33
    EBITDA Margin 7.88
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 9.57
    ROE % 11.50
    ROCE % 14.13
    Total Debt to Total Equity 0.64
    EBITDA Margin 9.84
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 8.41
    ROE % 2.75
    ROCE % 16.25
    Total Debt to Total Equity 0.05
    EBITDA Margin 6.83
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.11
    Total Assets 16.45
    Total Liabilities 16.45
    Total Equity 3.96
    Share Outstanding 4
    Price to Book Ratio 1.97
    Return on Assets (%) -4.09
    Return on Capital (%) -5.34
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.16
    Total Assets 19.50
    Total Liabilities 19.50
    Total Equity 4.63
    Share Outstanding 4
    Price to Book Ratio 5.75
    Return on Assets (%) 2.80
    Return on Capital (%) 5.58
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.14
    Total Assets 22.47
    Total Liabilities 22.47
    Total Equity 4.09
    Share Outstanding 4
    Price to Book Ratio 17.09
    Return on Assets (%) 2.66
    Return on Capital (%) 4.95
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 15.56
    Total Liabilities 15.56
    Total Equity 3.49
    Share Outstanding 0
    Price to Book Ratio 19.71
    Return on Assets (%) 2.13
    Return on Capital (%) 3.7
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments -3.09
    Total Assets 8.44
    Total Liabilities 8.44
    Total Equity 3.15
    Share Outstanding 0
    Price to Book Ratio 15.53
    Return on Assets (%) 0.89
    Return on Capital (%) 2.14
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 13.91
    Total Liabilities 13.91
    Total Equity 4.02
    Share Outstanding 4
    Price to Book Ratio 1.97
    Return on Assets (%) -4.99
    Return on Capital (%) -6.87
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 16.87
    Total Liabilities 16.87
    Total Equity 4.71
    Share Outstanding 4
    Price to Book Ratio 5.75
    Return on Assets (%) 1.88
    Return on Capital (%) 3.98
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.10
    Total Assets 20.44
    Total Liabilities 20.44
    Total Equity 4.39
    Share Outstanding 4
    Price to Book Ratio 17.09
    Return on Assets (%) 2.78
    Return on Capital (%) 5.19
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 14.20
    Total Liabilities 14.20
    Total Equity 3.82
    Share Outstanding 0
    Price to Book Ratio 19.71
    Return on Assets (%) 3.26
    Return on Capital (%) 5.62
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments -3.11
    Total Assets 7.93
    Total Liabilities 7.93
    Total Equity 3.36
    Share Outstanding 0
    Price to Book Ratio 15.53
    Return on Assets (%) 1.25
    Return on Capital (%) 2.82
    Particulars MAR 2025 (Values in Cr)
    Net Income -0.66
    Cash from Operations -2.49
    Cash from Investing 0.00
    Cash from Financing 2.45
    Net change in Cash -0.05
    Free Cash Flow -2.48
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.69
    Cash from Operations 2.19
    Cash from Investing -0.03
    Cash from Financing -1.98
    Net change in Cash 0.02
    Free Cash Flow 2.23
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.71
    Cash from Operations -0.82
    Cash from Investing 0.00
    Cash from Financing 1.03
    Net change in Cash 0.08
    Free Cash Flow -0.82
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.33
    Cash from Operations 2.46
    Cash from Investing 0.00
    Cash from Financing -2.47
    Net change in Cash -0.01
    Free Cash Flow 2.46
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.14
    Cash from Operations -3.02
    Cash from Investing -0.02
    Cash from Financing 2.79
    Net change in Cash -0.30
    Free Cash Flow -3.00
    Particulars MAR 2025 (Values in Cr)
    Net Income -0.69
    Cash from Operations -2.46
    Cash from Investing 0.00
    Cash from Financing 2.43
    Net change in Cash -0.04
    Free Cash Flow -2.46
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.42
    Cash from Operations 1.90
    Cash from Investing -0.03
    Cash from Financing -1.77
    Net change in Cash -0.01
    Free Cash Flow 1.94
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.68
    Cash from Operations 0.27
    Cash from Investing 0.00
    Cash from Financing -0.07
    Net change in Cash 0.08
    Free Cash Flow 0.27
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.46
    Cash from Operations -0.67
    Cash from Investing 0.00
    Cash from Financing 0.65
    Net change in Cash -0.02
    Free Cash Flow -0.67
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.14
    Cash from Operations -3.02
    Cash from Investing -0.02
    Cash from Financing 2.79
    Net change in Cash -0.30
    Free Cash Flow -3.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 12.79 1.49 236.18 23.12 38.85
    BLISS GVS PHARMA LTD 521.10 41.89 4.63 5526.59 118.35 552.90
    CIPLA LTD. 1438.75 30.53 3.37 116228.74 1165.55 1672.20
    FERMENTA BIOTECH LTD. 411.65 18.16 2.97 1211.53 256.40 415.70
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.82 21.55 3.97 236.18 23.12 38.85
    AMRUTAJAN HEALTH LTD 540.85 24.24 4.22 1563.63 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8123.85 106.10 23.26 20309.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 521.10 56.34 4.78 5526.59 118.35 552.90

    Vivanza Biosciences Limited shareholding pattern

    Holding
    79.97%
    20.01%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Vivanza Biosciences Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1.79 -5.78 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 1.90
    • 26 Days 1.90
    • 10 Days 0.00
    • 50 Days 1.90
    • 12 Days 1.90
    • 100 Days 1.90
    • 20 Days 1.90
    • 200 Days 2.10
    1.88 PIVOT
    First Support 1.84 First Resistance 1.93 Second Support 1.79 Second Resistance 1.97 Third Support 1.75 Third Resistance 2.02
    RSI 45.44 ADX 11.90 MACD 0.03 Williams % R -72.34 Commodity Channel Index (CCI) -81.56
    Date 2026-07-09 Week 9329.00 Same Day 18510.00 Month 22411.00
    1 Year 0.48 3 Year 0.34
    Over 1 Month
    4.67% down
    Over 1 Year
    -14.76% down
    Over 3 Months
    -14.35% down
    Over 3 Years
    -45.63% down
    Over 6 Months
    -17.12% down
    Over 5 Years
    -33.35% down

    Vivanza Biosciences Limited Corporate Actions

    Ex-Date Old FV NEW FV Record Date
    24 Mar 2023 10.0 1.0 24 Mar 2023

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Vivanza Biosciences Ltd?

    Answer Field

    Vivanza Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1.79 as on Jul 10 2026 03:15 PM.

    What is the Market Cap of Vivanza Biosciences Ltd Share?

    Answer Field

    The market cap of Vivanza Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 7.20 as on Jul 10 2026 03:15 PM.

    What is the 52 Week High and Low of Vivanza Biosciences Ltd?

    Answer Field

    The 52 Week High and Low of Vivanza Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 2.72 and ₹ 1.52.

    What is 1 year return for Vivanza Biosciences Ltd?

    Answer Field

    The 1 year returns on the stock has been -14.76%.

    What is the P/E Ratio of Vivanza Biosciences Ltd Share?

    Answer Field

    As on Jul 10 2026 03:15 PM the price-to-earnings (PE) ratio for Vivanza Biosciences Ltd share is 19.89.

    What is the PB ratio of Vivanza Biosciences Ltd Share?

    Answer Field

    As on Jul 10 2026 03:15 PM, the price-to-book (PB) ratio for Vivanza Biosciences Ltd share is 1.10.

    How to Buy Vivanza Biosciences Ltd Share?

    Answer Field

    You can trade in Vivanza Biosciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Vivanza Biosciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Vivanza Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Vivanza Biosciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |